Baidu
map

感染

订阅

MedSci主页 / 所有栏目 / 感染

一图读懂：免疫应答

2015-09-09 佚名 医学美图

免疫应答T细胞B细胞抗体
关注

免疫应答 T细胞 B细胞 抗体

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=43804, encodeId=c0e2438041a, content=image, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ec81665998, createdName=1ddfd4fem35(暂无匿称), createdTime=Wed Nov 25 16:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42936, encodeId=d3ea4293676, content=长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d4e1658739, createdName=1dde3e58m58(暂无匿称), createdTime=Tue Nov 10 06:34:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42776, encodeId=9eb242e769f, content=很形象！, beContent=null, objectType=article, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151101/IMG5635562CC617F7689.jpg, createdBy=bf351605554, createdName=xjbtdbs150wgf, createdTime=Sat Nov 07 23:00:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36826, encodeId=c1bb368266b, content=不错哦，很形象。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d02b1457017, createdName=673782458, createdTime=Sat Sep 12 00:33:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400216, encodeId=4a92140021613, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Sep 11 06:10:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-11-25 1ddfd4fem35(暂无匿称)

    image

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=43804, encodeId=c0e2438041a, content=image, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ec81665998, createdName=1ddfd4fem35(暂无匿称), createdTime=Wed Nov 25 16:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42936, encodeId=d3ea4293676, content=长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d4e1658739, createdName=1dde3e58m58(暂无匿称), createdTime=Tue Nov 10 06:34:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42776, encodeId=9eb242e769f, content=很形象！, beContent=null, objectType=article, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151101/IMG5635562CC617F7689.jpg, createdBy=bf351605554, createdName=xjbtdbs150wgf, createdTime=Sat Nov 07 23:00:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36826, encodeId=c1bb368266b, content=不错哦，很形象。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d02b1457017, createdName=673782458, createdTime=Sat Sep 12 00:33:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400216, encodeId=4a92140021613, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Sep 11 06:10:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-11-10 1dde3e58m58(暂无匿称)

    长知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=43804, encodeId=c0e2438041a, content=image, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ec81665998, createdName=1ddfd4fem35(暂无匿称), createdTime=Wed Nov 25 16:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42936, encodeId=d3ea4293676, content=长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d4e1658739, createdName=1dde3e58m58(暂无匿称), createdTime=Tue Nov 10 06:34:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42776, encodeId=9eb242e769f, content=很形象！, beContent=null, objectType=article, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151101/IMG5635562CC617F7689.jpg, createdBy=bf351605554, createdName=xjbtdbs150wgf, createdTime=Sat Nov 07 23:00:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36826, encodeId=c1bb368266b, content=不错哦，很形象。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d02b1457017, createdName=673782458, createdTime=Sat Sep 12 00:33:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400216, encodeId=4a92140021613, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Sep 11 06:10:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-11-07 xjbtdbs150wgf

    很形象！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=43804, encodeId=c0e2438041a, content=image, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ec81665998, createdName=1ddfd4fem35(暂无匿称), createdTime=Wed Nov 25 16:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42936, encodeId=d3ea4293676, content=长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d4e1658739, createdName=1dde3e58m58(暂无匿称), createdTime=Tue Nov 10 06:34:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42776, encodeId=9eb242e769f, content=很形象！, beContent=null, objectType=article, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151101/IMG5635562CC617F7689.jpg, createdBy=bf351605554, createdName=xjbtdbs150wgf, createdTime=Sat Nov 07 23:00:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36826, encodeId=c1bb368266b, content=不错哦，很形象。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d02b1457017, createdName=673782458, createdTime=Sat Sep 12 00:33:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400216, encodeId=4a92140021613, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Sep 11 06:10:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-09-12 673782458

    不错哦，很形象。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=43804, encodeId=c0e2438041a, content=image, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ec81665998, createdName=1ddfd4fem35(暂无匿称), createdTime=Wed Nov 25 16:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42936, encodeId=d3ea4293676, content=长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d4e1658739, createdName=1dde3e58m58(暂无匿称), createdTime=Tue Nov 10 06:34:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42776, encodeId=9eb242e769f, content=很形象！, beContent=null, objectType=article, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151101/IMG5635562CC617F7689.jpg, createdBy=bf351605554, createdName=xjbtdbs150wgf, createdTime=Sat Nov 07 23:00:00 CST 2015, time=2015-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36826, encodeId=c1bb368266b, content=不错哦，很形象。, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d02b1457017, createdName=673782458, createdTime=Sat Sep 12 00:33:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1400216, encodeId=4a92140021613, content=<a href='/topic/show?id=10cc2901458' target=_blank style='color:#2F92EE;'>#免疫应答#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29014, encryptionId=10cc2901458, topicName=免疫应答)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a602256775, createdName=clmlylxy, createdTime=Fri Sep 11 06:10:00 CST 2015, time=2015-09-11, status=1, ipAttribution=)]
    2015-09-11 clmlylxy

    #免疫应答#

    0

相关资讯

Immunity：肠道菌群或可增强流感疫苗的免疫效果

据路透社纽约健康专栏消息，一项在小鼠中的研究显示，肠道菌群成分可能会影响季节性流感疫苗的免疫效果。 本研究的共同作者，来自佐治亚州亚特兰大埃默里疫苗研究中心的Bali Pulendran博士表示，“肠道细菌会表达一种称为鞭毛蛋白的蛋白质，可激活免疫细胞中的TLR5受体（Toll样受体5），从而发生对流感疫苗的免疫应答，增加抗体的产生。” Pulendran博士随后表示，在人类中，通过抗菌药物治

Nat Commun：整合素可使T细胞不再产生免疫应答

2014年11月3日 讯 /生物谷BIOON/ --近日研究发现，当整合素释放它们的配体和树突细胞内的肌动蛋白细胞骨架时，另一个细胞表面受体gm - csf的活性就会增强，增强的信号诱导树突状细胞刺激淋巴结激活T细胞。 整合素是一种粘附分子并能够在细胞表面进行表达。它们在细胞“整合”的外部与细胞内部细胞骨架中起着非常重要的作用。beta2-整联蛋白系在树突状细胞中有较高量的表达，这对免疫应答

PNAS：实时成像肿瘤免疫应答

科学家们开发了一种新技术，能够不进行抽血或者组织活检，实时成像免疫系统对肿瘤的应答。这一成果发表在本周的美国国家科学院院刊PNAS杂志上，是诊断癌症和监控治疗效果的一大突破。“每一个免疫学家都希望能够监控免疫应答的进行，我们有哪些选择呢？”这项研究的领导者，Whitehead研究所的著名免疫学家Hidde Ploegh介绍到。“我们可以检测血液，但血液只是免疫细胞的运输工具，并不是免疫应答的发生地

Oncogene：中科院健康所发现增强免疫应答抗肿瘤新机制

近日，来自中国科学院上海健康科学研究所的时玉舫研究员在著名国际期刊oncogene在线发表了他们关于抗肿瘤免疫应答的最新研究进展。他们通过研究发现利用组蛋白去乙酰化酶抑制剂(HDACI)抑制CD4+T细胞激活诱导的细胞死亡（AICD）过程能够有效增强抗肿瘤免疫应答过程，对于利用免疫应答治疗肿瘤具有重要意义。 研究人员指出，体内抗肿瘤免疫应答的低效性部分源于T细胞不能对肿瘤产生有效应答。而发生在T细

Science：VirScan可揭示一个人完整的病毒接触史

一种叫做VirScan的新技术只需不到一滴血的量便能确定一个人在其一生中所接触过的所有病毒。研究人员对来自世界各地569人使用了该筛检技术并发现，平均而言，他们的实验参与者在其一生中接触过大约10种病毒。VirScan为研究人类病毒组（已知会感染人的各种病毒汇集）和免疫系统（它会因接触病毒而永久性地改变）之间的相互作用提供了一个强有力而且廉价的工具。在此之前，用来检测病毒遗留下来的无法抹灭足迹的血

Nature Immunology：MST4磷酸化TRAF6抑制免疫应答新机制

              近日，来自中国科学院上海生化细胞所的周兆才研究组在著名国际生物学顶尖期刊Nature  Immunology刊登了他们的一项最新研究成果，他们首次发现生发中心激酶MST4能够直接磷酸化TRAF6，抑制免疫应答反应。该

Baidu
map
Baidu
map
Baidu
map